Showing results (341-350 of 554) with videos related to

Sort By:
Pageof 56
Cancer Medicine|April 1, 2024
Characterization and impact of non-canonical WNT signaling on outcomes of urothelial carcinomaMargaret Meagher, Harris Krause, Andrew Elliott, et al.
The Oncologist|October 7, 2025
Molecular and clinical correlates of high FOLH1 (PSMA) RNA expression in primary and metastatic prostate cancerRana R McKay, Shayan S Nazari, Andrew Elliott, et al.
ESMO Open|June 11, 2025
Uncovering PD-L1 among immune cell predictive biomarkers and actionable genetic alterations in anal squamous-cell carcinomas in the era of immunotherapyG Sharma, Y Baca, A F Shields, et al.
The Prostate|April 8, 2026
Castration Resistance Accelerates Prostate Cancer KineticsSheila Jonnatan, Luka Cavka, Angelo M De Marzo, et al.
Nature Communications|June 3, 2020
The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancerKeliang Wang, Jie Luo, Shuyuan Yeh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2023
PSMA-positive Circulating Tumor Cell Detection and Outcomes with Abiraterone or Enzalutamide Treatment in Men with Metastatic Castrate-resistant Prostate CancerSantosh Gupta, Susan Halabi, Qian Yang, et al.
Prostate Cancer and Prostatic Diseases|April 1, 2026
Cytoplasmic versus nuclear localization of androgen receptor splice variant 7 as a predictor of benefit from androgen receptor pathway inhibitors in metastatic castration-resistant prostate cancer (PROPHECY trial)Santosh Gupta, Siyuan Guo, Susan Halabi, et al.
Clinical Genitourinary Cancer|September 19, 2019
PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer After Radical ProstatectomyMark C Markowski, Yongmei Chen, Zhaoyong Feng, et al.
JCO Precision Oncology|September 7, 2023
Opposing Roles of SPOP Mutations in Human Prostate and Endometrial CancersLudimila Cavalcante, Sachin Kumar Deshmukh, Jennifer R Ribeiro, et al.
Clinical Proteomics|July 12, 2026
Targeted proteomics for the detection of androgen receptor variants in preclinical models of castration-resistant prostate cancerZoi E Sychev, Gabrianne Larson, Megan L Ludwig, et al.
Pageof 56